These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 27917262)

  • 1. Toll-like receptors in pathophysiology of liver diseases.
    Kiziltas S
    World J Hepatol; 2016 Nov; 8(32):1354-1369. PubMed ID: 27917262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptors and liver disease.
    Kesar V; Odin JA
    Liver Int; 2014 Feb; 34(2):184-96. PubMed ID: 24118797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptors and metabolic (dysfunction)-associated fatty liver disease.
    Khanmohammadi S; Kuchay MS
    Pharmacol Res; 2022 Nov; 185():106507. PubMed ID: 36252773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of toll-like receptors in immune activation and tolerance in the liver.
    Nakamoto N; Kanai T
    Front Immunol; 2014; 5():221. PubMed ID: 24904576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor signaling and liver fibrosis.
    Aoyama T; Paik YH; Seki E
    Gastroenterol Res Pract; 2010; 2010():. PubMed ID: 20706677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptors: Significance, ligands, signaling pathways, and functions in mammals.
    Vidya MK; Kumar VG; Sejian V; Bagath M; Krishnan G; Bhatta R
    Int Rev Immunol; 2018 Jan; 37(1):20-36. PubMed ID: 29028369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular TLRs of Mast Cells in Innate and Acquired Immunity.
    Ogawa Y; Kinoshita M; Kawamura T; Shimada S
    Handb Exp Pharmacol; 2022; 276():133-159. PubMed ID: 34505203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity.
    Duan T; Du Y; Xing C; Wang HY; Wang RF
    Front Immunol; 2022; 13():812774. PubMed ID: 35309296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system.
    Netea MG; van der Graaf C; Van der Meer JW; Kullberg BJ
    J Leukoc Biol; 2004 May; 75(5):749-55. PubMed ID: 15075354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptors as targets in chronic liver diseases.
    Mencin A; Kluwe J; Schwabe RF
    Gut; 2009 May; 58(5):704-20. PubMed ID: 19359436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-Like Receptors in the Pathogenesis of Autoimmune Diseases.
    Mohammad Hosseini A; Majidi J; Baradaran B; Yousefi M
    Adv Pharm Bull; 2015 Dec; 5(Suppl 1):605-14. PubMed ID: 26793605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptors and adaptor molecules in liver disease: update.
    Seki E; Brenner DA
    Hepatology; 2008 Jul; 48(1):322-35. PubMed ID: 18506843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptors in liver fibrosis: cellular crosstalk and mechanisms.
    Yang L; Seki E
    Front Physiol; 2012; 3():138. PubMed ID: 22661952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like Receptors in the Vascular System: Sensing the Dangers Within.
    Goulopoulou S; McCarthy CG; Webb RC
    Pharmacol Rev; 2016 Jan; 68(1):142-67. PubMed ID: 26721702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-Like Receptors in Adaptive Immunity.
    Kumar V
    Handb Exp Pharmacol; 2022; 276():95-131. PubMed ID: 34510306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives.
    Mukherjee S; Patra R; Behzadi P; Masotti A; Paolini A; Sarshar M
    Front Immunol; 2023; 14():1244345. PubMed ID: 37822929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooperation of liver cells in health and disease.
    Kmieć Z
    Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses.
    Ma Z; Zhang E; Yang D; Lu M
    Cell Mol Immunol; 2015 May; 12(3):273-82. PubMed ID: 25418467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptors: the swiss army knife of immunity and vaccine development.
    Dowling JK; Mansell A
    Clin Transl Immunology; 2016 May; 5(5):e85. PubMed ID: 27350884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets.
    Kumar V
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107087. PubMed ID: 33075714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.